高危早期肺癌患者中亚肺叶切除并非总是更优
本研究将因一般状况可能不符合日本临床肿瘤学组0802试验条件的患者归为高危组,其余归为正常风险组,比较两组总生存及高危组预后因素。高危组254例(19.4%),正常风险组1054例,5年生存率分别为79.1%和94.5%(P < 0.001)。高危组中肺叶切除151例、亚肺叶切除103例,两种术式的肺癌死亡与非肺癌死亡数均无显著差异。
要点
- 高危组5年生存率79.1%,低于正常风险组的94.5%(P < 0.001)。
- 高危组肺癌死亡和非肺癌死亡均多于正常风险组(P < 0.001)。
- 高危组中亚肺叶切除与肺叶切除的肺癌死亡及非肺癌死亡数无显著差异。
核心结论
- 亚肺叶切除对早期肺癌并非总是更优,即使在高危患者中,手术方式也应结合患者背景和肺癌监测来确定。
研究设计与样本
- 将因一般状况可能不符合日本临床肿瘤学组0802试验条件的患者归为高危组,无此风险者归为正常风险组,分析高危组的总生存和预后因素。
- 高危组254例(19.4%),正常风险组1054例。
主要发现
- 正常风险组5年生存率为94.5%,高危组为79.1%(P < 0.001)。
- 高危组死于肺癌(P < 0.001)和非肺癌死亡(P < 0.001)的患者均多于正常风险组。
- 高危组中行肺叶切除151例、亚肺叶切除103例,两种术式的肺癌死亡数和非肺癌死亡数均无显著差异。
- 分层生存分析显示,一氧化碳弥散量 < 40% 倾向于支持亚肺叶切除;女性和癌胚抗原水平高倾向于支持肺叶切除。
临床怎么用
- 作者认为,亚肺叶切除对早期肺癌并非总是更优,即使在高危患者中,手术方式也应结合患者背景和肺癌监测来确定。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The phase III trial, Japan Clinical Oncology Group 0802, illustrated the superiority of sublobar resection for early-stage lung cancer in terms of overall survival, with more non-lung cancer-related deaths after a lobectomy. The advantages of sublobar resection may be more pronounced in high-risk patients. The goal of this study was to elucidate the prognoses of high-risk patients. METHODS: Patients with a risk of being ineligible for Japan Clinical Oncology Group 0802 for general conditions were classified as the high-risk group, and those who were not at risk of being ineligible were classified as the normal-risk group. Overall survival and prognostic factors were analysed in the high-risk group. RESULTS: There were 254 (19.4%) and 1054 patients in the high- and normal-risk groups, respectively. Five-year survival rates were 94.5% and 79.1% in the normal-risk and high-risk groups, respectively (P < 0.001). More patients in the high-risk group died of lung cancer (P < 0.001) and non-lung cancer deaths (P < 0.001) than patients in the normal-risk group.In the high-risk group, 151 lobectomies and 103 sublobar resections were performed. There was no significant difference in the numbers of lung cancer deaths and of non-lung cancer deaths between the procedures. Stratified survival analyses showed that the diffusing capacity of the lungs for carbon monoxide < 40% tended to favour sublobar resection; being female and having a high carcinoembryonic antigen level tended to favour a lobectomy. CONCLUSIONS: Sublobar resection is not always superior for early-stage lung cancer. Even in such cases, the surgical method should be determined by taking into consideration the patient's background and lung cancer surveillance.
引用
- Fukui M, Matsunaga T, Hattori A, et al. Sublobar resection is not always superior for early-stage lung cancer in high-risk patients. Eur J Cardiothorac Surg. 2024. PMID: 37756703. doi:10.1093/ejcts/ezad325
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。